Literature DB >> 11888973

A randomized clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation.

Kees Smulders1, Hans van der Hoeven, Ineke Weers-Pothoff, Christina Vandenbroucke-Grauls.   

Abstract

OBJECTIVE: To study the effect of subglottic secretions drainage on the incidence of ventilator-associated pneumonia (VAP) in patients receiving mechanical ventilation.
DESIGN: A randomized clinical trial.
SETTING: A 12-bed general ICU. PATIENTS: One hundred fifty patients with an expected duration of mechanical ventilation > 72 h were enrolled in the study. INTERVENTION: Patients were randomly assigned to receive either an endotracheal tube for intermittent subglottic secretions drainage or a standard endotracheal tube. OUTCOME MEASUREMENTS: Incidence of VAP, duration of mechanical ventilation, length of ICU stay, length of hospital stay, and mortality.
RESULTS: Seventy-five patients were randomized to subglottic secretion drainage, and 75 patients were randomized to the control group. The two groups were similar at the time of randomization with respect to demographic characteristics and severity of illness. VAP was seen in 3 patients (4%) receiving suction secretion drainage and in 12 patients (16%) in the control group (relative risk, 0.22; 95% confidence interval, 0.06 to 0.81; p = 0.014). The other outcome measures were not significantly different between the two groups.
CONCLUSION: Intermittent subglottic secretion drainage reduces the incidence of VAP in patients receiving mechanical ventilation.

Entities:  

Mesh:

Year:  2002        PMID: 11888973     DOI: 10.1378/chest.121.3.858

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  34 in total

Review 1.  Ventilator-associated pneumonia: current status and future recommendations.

Authors:  Shai Efrati; Israel Deutsch; Massimo Antonelli; Peter M Hockey; Ronen Rozenblum; Gabriel M Gurman
Journal:  J Clin Monit Comput       Date:  2010-03-17       Impact factor: 2.502

2.  Ventilator-associated pneumonia: diagnosis, treatment, and prevention.

Authors:  Steven M Koenig; Jonathon D Truwit
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

3.  Comment on "antibacterial-coated tracheal tubes cleaned with a Mucus Shaver" by Berra et al.

Authors:  Peter E Spronk; Johannes H Rommes; Marcus J Schultz
Journal:  Intensive Care Med       Date:  2006-10-13       Impact factor: 17.440

4.  Oral care reduces incidence of ventilator-associated pneumonia in ICU populations.

Authors:  Hideo Mori; Hiroyuki Hirasawa; Shigeto Oda; Hidetoshi Shiga; Kenichi Matsuda; Masataka Nakamura
Journal:  Intensive Care Med       Date:  2006-01-25       Impact factor: 17.440

Review 5.  Updating the evidence-base for suctioning adult patients: a systematic review.

Authors:  Tom J Overend; Cathy M Anderson; Dina Brooks; Lisa Cicutto; Michael Keim; Debra McAuslan; Mika Nonoyama
Journal:  Can Respir J       Date:  2009 May-Jun       Impact factor: 2.409

Review 6.  Technologic advances in endotracheal tubes for prevention of ventilator-associated pneumonia.

Authors:  Juan F Fernandez; Stephanie M Levine; Marcos I Restrepo
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

7.  Preventing aspiration during peroral endoscopic myotomy.

Authors:  Payal Saxena; Richard Pippenger; Mouen A Khashab
Journal:  J Anesth       Date:  2014-08-13       Impact factor: 2.078

8.  Impact of selective digestive decontamination on respiratory tract Candida among patients with suspected ventilator-associated pneumonia. A meta-analysis.

Authors:  J C Hurley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-26       Impact factor: 3.267

9.  The role of the endotracheal tube cuff in microaspiration.

Authors:  V Anne Hamilton; Mary Jo Grap
Journal:  Heart Lung       Date:  2011-12-30       Impact factor: 2.210

10.  The paradox of ventilator-associated pneumonia prevention measures.

Authors:  Michael Klompas
Journal:  Crit Care       Date:  2009-10-15       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.